• 1
    Sigmund CD. Viewpoint: are studies in genetically altered mice out of control? Arterioscler Thromb Vasc Biol 2000; 20: 14251429.
  • 2
    Linder CC. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Lab Animal 2001; 30: 3439.
  • 3
    Brook FA, Gardner RL. The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci USA 1997; 94: 57095712.
  • 4
    Auerbach W, Dunmore JH, Fairchild-Huntress V, et al. Establishment and chimera analysis of 129/SvEV- and C57BL/6-derived mouse embryonic stem cell lines. BioTechniques 2000; 29: 10241028.
  • 5
    Hogan E, Costantini F, Lacy E. Manipulating the Mouse Embryo. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1986.
  • 6
    Eggan K, Akutsu H, Loring J, et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci USA 2001; 98: 62096214.
  • 7
    Schoonjans L, Moreadith R. Pluripotent embryonic stem (ES) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals. WO 02/00847A2, January 3, 2002.
  • 8
    Bradley A. Production and analysis of chimeric mice. In: RobertsonEJ, ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford: JRI Press Ltd.,1987:113151.
  • 9
    Robertson EJ. Embryo-derived stem cell lines. In: RobertsonEJ, ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford: JRI Press Ltd., 1987:71112.
  • 10
    Nagy A, Rossant J, Nagy R, et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 1993; 90: 84248428.
  • 11
    Roach ML, Stock JL, Byrum R, et al. A new embryonic stem-cell line from DBA/1lAcJ mice allows genetic modification in a murine model of human inflammation. Exp Cell Res 1995; 221: 520525.
  • 12
    Threadgill DW, Yee D, Matin A, et al. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome 1997; 8: 390393.
  • 13
    Williams RL, Hilton DJ, Pease S, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988; 336: 684687.
  • 14
    Nichols J, Evans EP, Smith AG. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 1990; 110: 13411348.
  • 15
    Pease S, Braghetta P, Gearing D, et al. Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev Biol 1990; 141: 344352.
  • 16
    Nichols J, Chambers I, Smith A. Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor. Exp Cell Res 1994; 215: 237239.